Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-29

Clinical Trial Update: Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body. [Phase 3]

View source ↗

Summary

Phase 3 trial in children with immune thrombocytopenia (Idiopathic Thrombocytopenic Purpura) evaluating a new medication has completed. Results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GlaxoSmithKline | Conditions: Idiopathic Thrombocytopenic Purpura | Phase 3 | Status: COMPLETED | Results posted: 2014-09-29